Insights from the REIMAGINE Trial: Robust Glycaemic Control and Meaningful Weight Loss with Cagri Sema Across DiverseT2D Population
by Prateek Chopra | June 29, 2026 | Diabetes Conferences | ADA 2026 Therapy Overview REIMAGINE Trial Programme Glycemic Outcomes Weight Loss Outcomes Benefits in Insulin-Treated T2D Safety Profile Clinical Implications The REIMAGINE programme showed that CagriSema delivers substantial improvements in glycemic control and body weight across diverse T2D populations. Its consistent efficacy and favorable safety profile support its potential […]